Does anyone know when the $36.9m in TD investments matured? 183 days since the CR would suggests to me that this would simply be held as additional cash now, or a portion rolled over and reinvested, but nothing in the accounts in this regard. What are investors' thoughts on the cash levels to see us through this year's R&D and admin expenditure? Anyone expect cost increases of any significance in ramping up CANVAS clinical trials during 2012? $4.1m Saxony grant for European trials nice to have tucked away and ready.
- Forums
- ASX - By Stock
- IMM
- half yearly report
half yearly report, page-2
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $581.0M |
Open | High | Low | Value | Volume |
38.5¢ | 41.0¢ | 38.5¢ | $1.351M | 3.389M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16911 | 40.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.5¢ | 154170 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16911 | 0.400 |
6 | 104590 | 0.395 |
6 | 65668 | 0.390 |
6 | 98699 | 0.385 |
10 | 114110 | 0.380 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 154170 | 1 |
0.410 | 259670 | 7 |
0.415 | 187366 | 8 |
0.420 | 484307 | 7 |
0.425 | 69000 | 3 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |